Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 10, 2022 16:05 ET | Source: Femasys Inc.

Femasys Inc. Announces Financial Results for the Second Quarter Ended June 30, 2022 and Provides Corporate Update

Continued focus and progress with FemaSeed® and FemBloc® biomedical product candidates in developmentFemCerv® and FemCath™ commercial availability expected by year-end ATLANTA, Aug. 10, 2022 ...
August 03, 2022 08:00 ET | Source: Femasys Inc.

Femasys To Participate in Upcoming BTIG Biotechnology Conference

ATLANTA, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
July 20, 2022 07:00 ET | Source: Femasys Inc.

Femasys To Host Key Opinion Leader Event on FemBloc, a First-of-its-Kind Medical Solution for Permanent Birth Control and an Important Option for Women Post Overturn of Roe v. Wade

ATLANTA, July 20, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
July 11, 2022 08:30 ET | Source: Femasys Inc.

Femasys to Participate in the Women’s Health Panel Discussion Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, July 13th at 11 a.m. ET

ATLANTA, July 11, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
July 06, 2022 08:00 ET | Source: Femasys Inc.

Femasys Inc. Announces Existing Board Member Charles Larsen as Chairperson of the Board

ATLANTA, July 06, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
June 15, 2022 08:00 ET | Source: Femasys Inc.

Femasys Inc. to Present at the LSX World Congress USA 2022

ATLANTA, June 15, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
May 11, 2022 16:05 ET | Source: Femasys Inc.

Femasys Inc. Announces Financial Results for the First Quarter Ended March 31, 2022

- Furthers advancement of much-needed minimally invasive technologies for underserved areas of women’s health with pending commercialization of products, FemCerv® and FemCath™ expected by year-end ...
March 25, 2022 08:00 ET | Source: Femasys Inc.

Femasys Inc. to Participate in the M-Vest 2022 Virtual Growth Conference

ATLANTA, March 25, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include...
March 24, 2022 16:05 ET | Source: Femasys Inc.

Femasys Inc. Announces Financial Results for the Year Ended December 31, 2021

-- Company builds out management team and continues to implement its clinical programs to advance much-needed technologies for women’s health -- ATLANTA, March 24, 2022 (GLOBE NEWSWIRE) -- Femasys...
February 24, 2022 08:00 ET | Source: Femasys Inc.

Femasys Inc. Announces the Appointment of Dov Elefant to New Position of Chief Financial Officer

-- Seasoned financial executive with 25 years of experience leading public and private biotech companies throughout various stages -- ATLANTA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Femasys Inc....